We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$204M
AUM Growth
+$4.3M
Cap. Flow
-$483K
Cap. Flow %
-0.24%
Top 10 Hldgs %
40.19%
Holding
155
New
7
Increased
67
Reduced
64
Closed
8

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.63M
2
BX icon
Blackstone
BX
+$1.43M
3
KKR icon
KKR & Co
KKR
+$826K
4
MSFT icon
Microsoft
MSFT
+$390K
5
APO icon
Apollo Global Management
APO
+$378K

Sector Composition

Rank Sector Weight
1 Financials 18.62%
2 Technology 16.07%
3 Communication Services 3.64%
4 Consumer Discretionary 2.94%
5 Healthcare 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUG icon
76
Global X Cybersecurity ETF
BUG
$1.38B
$558K 0.27%
17,400
+1,240
+8% +$40.2K
SCHD icon
77
Schwab US Dividend Equity ETF
SCHD
$104B
$557K 0.27%
20,384
+170
+0.8% +$4.83K
QQQ icon
78
Invesco QQQ Trust
QQQ
$469B
$557K 0.27%
1,089
-15
-1% -$7.59K
FTCS icon
79
First Trust Capital Strength ETF
FTCS
$7.86B
$535K 0.26%
6,088
-438
-7% -$39.9K
BAC icon
80
Bank of America
BAC
$435B
$515K 0.25%
11,728
-673
-5% -$29.6K
BLK icon
81
Blackrock
BLK
$169B
$512K 0.25%
+499
New +$506K
ABBV icon
82
AbbVie
ABBV
$443B
$505K 0.25%
2,840
-76
-3% -$14K
MC icon
83
Moelis & Co
MC
$4.97B
$503K 0.25%
6,812
+323
+5% +$23.4K
VIOO icon
84
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.22B
$503K 0.25%
4,741
+18
+0.4% +$1.99K
LAZ icon
85
Lazard
LAZ
$4.13B
$498K 0.24%
9,670
-98
-1% -$5.25K
SDY icon
86
State Street SPDR S&P Dividend ETF
SDY
$23.6B
$494K 0.24%
3,239
-388
-11% -$54.2K
DUK icon
87
Duke Energy
DUK
$97.8B
$486K 0.24%
4,515
-83
-2% -$9.4K
LOW icon
88
Lowe's Companies
LOW
$117B
$483K 0.24%
1,959
-44
-2% -$11.8K
KEY icon
89
KeyCorp
KEY
$24.2B
$478K 0.23%
27,869
-2,697
-9% -$48.4K
SO icon
90
Southern Company
SO
$109B
$475K 0.23%
5,772
+5
+0.1% +$439
AVGO icon
91
Broadcom
AVGO
$1.85T
$464K 0.23%
2,022
-220
-10% -$40.7K
IVV icon
92
iShares Core S&P 500 ETF
IVV
$884B
$461K 0.23%
783
+21
+3% +$12.4K
MFC icon
93
Manulife Financial
MFC
$73.9B
$453K 0.22%
14,760
-2,024
-12% -$62.7K
PFE icon
94
Pfizer
PFE
$143B
$451K 0.22%
17,011
-1,779
-9% -$48.3K
BXP icon
95
Boston Properties
BXP
$11.2B
$438K 0.21%
5,890
+645
+12% +$52.3K
BMY icon
96
Bristol-Myers Squibb
BMY
$133B
$433K 0.21%
7,661
+158
+2% +$8.83K
VTV icon
97
Vanguard Morningstar Value ETF
VTV
$189B
$419K 0.21%
2,473
+7
+0.3% +$1.23K
SPG icon
98
Simon Property Group
SPG
$74.4B
$415K 0.2%
2,408
-299
-11% -$52.5K
GSEW icon
99
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.93B
$415K 0.2%
+5,370
New +$426K
ICVT icon
100
iShares Convertible Bond ETF
ICVT
$7.32B
$410K 0.2%
4,823

Similar funds

O'Rourke & Company's Q4 2024 Portfolio in Review

As of Q4 2024, O'Rourke & Company held 155 positions worth $204M, up 2.2% from $200M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

O'Rourke & Company's Q4 2024 filing shows 7 new, 67 increased, 64 reduced and 8 closed positions. Its largest new stake was Invesco S&P 500 Equal Weight Income Advantage ETF: 11,997 shares worth $604K. The largest sale was Apple, an estimated $1.63M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.

  • O'Rourke & Company's largest Q4 2024 buy was Invesco S&P 500 Equal Weight Income Advantage ETF: 11,997 shares worth $604K.
  • O'Rourke & Company added most to JPMorgan Income ETF in Q4 2024, an estimated $2.2M increase.
  • O'Rourke & Company's biggest Q4 2024 reduction was Apple, cutting an estimated $1.63M.
  • O'Rourke & Company fully exited iShares Core S&P Mid-Cap ETF in Q4 2024, selling an estimated $232K.
  • O'Rourke & Company's ten largest holdings make up 40% of its $204M portfolio in Q4 2024.
  • O'Rourke & Company opened 7 new positions and closed 8 in Q4 2024.
  • O'Rourke & Company's portfolio value rose 2.2% quarter-over-quarter to $204M.

Based on O'Rourke & Company's 13F filing for Q4 2024, filed 13 Feb 2025.